Upstream & Downstream Bioprocessing | Whitepapers & Reports

Accelerating Upstream Process Development with Direct CQA and Media Analysis Feedback

Upstream Bioprocess Development.

CQA data is important in biopharma development, but results are often returned weeks after samples are taken. Let's change this!

  • Are you a Cell Line Development Scientist or a Process Engineer?
  • Is your goal to optimize biotherapeutics manufacturing processes?
  • Do you want to maximize the quality, yield, and efficiency of drug manufacturing?

Then you should continue reading:

Currently, information on product quality and media composition is not readily available: the measurement, analysis and results are generally lagging by several weeks.

Direct measurement of Product Quality Attributes (PQAs) and spent media information is now available thanks to dedicated workflows coupling small bioreactors like the Sartorius Ambr® 15 or 250 systems to the Waters BioAccordâ„¢ LC-MS system.

With this integrated solution, process engineers have access to the information they need to stay in control: drug substance quality and yield can be maximized, and downstream impurities minimized.

Would you like to know more about it?